OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

OncoDaily is proud to host a special live session during the ASCO 2026 Annual Meeting in Chicago: OncoDaily Grand Rounds at ASCO: Sarcoma Edition with Dr. Sandra D’Angelo and Dr. Herbert Loong. This exclusive program will convene renowned experts who will highlight the developments shaping the sarcoma field and provide a deeper understanding of how the latest evidence may influence treatment strategies and future directions in sarcoma care.

The event’s Bronze sponsor is US WorldMeds.

Event Details

DATE: Friday, May 29, 2026

TIME: 3:30 – 5:30 pm (Chicago Time)

LOCATION: Hilton Chicago, 720 S Michigan Ave, Chicago, IL 60605, United States

Registration is available online

Co-Chairs

Images	Name
	Sandra D'Angelo, MD Medical oncologist at Memorial Sloan Kettering Cancer Center, specializing in the care of soft tissue sarcomas and bone sarcomas, as well as Merkel cell carcinoma
	Herbert Loong, MD, FASCO Clinical Associate Professor, Department of Clinical Oncology, Medical Director (Oncology), Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong

Speakers

Images	Name
	Javier Martín-Broto Founder Member of The Spanish Group for Research on Sarcomas (GEIS) in 1994 and member of the executive committee of GEIS since 1994 (He was GEIS Chairman from 2010 to 2018) to 2022. He obtained PhD degree in Molecular Biology in 2010 focusing on molecular prognostic biomarkers in GIST. Currently, he coordinates clinical sarcoma assistance with translational research, leading a basic research team in the lab in Fundación Jimenez Diaz University Hospital, in Madrid. He leads the Sarcoma Latin-American & European Sarcoma Network (SELNET) consortium. Additionally, he’s running and designing several trials on sarcoma patients, some of them as the coordinator at national and international levels. He is the author/co-author of more than 400 publications on sarcoma.
	Robin Jones Medical oncologist specialising in the treatment of bone and soft tissue sarcomas and Head of the Sarcoma Unit at The Royal Marsden. He has experience in conducting Phase I, II and III trials, as well translational studies in sarcomas. Professor Jones trained in medical oncology at The Royal Marsden and between 2010 and 2014 he was Head of the Sarcoma Program at the University of Washington/Fred Hutchinson Cancer Research Center in Seattle. His main research interest focuses on clinical trials and translational research in sarcomas.